Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus

Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus

FromPharma Market Access Insights - from Mtech Access


Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus

FromPharma Market Access Insights - from Mtech Access

ratings:
Length:
61 minutes
Released:
Jan 13, 2021
Format:
Podcast episode

Description

With new policy passing power to Integrated Care Systems (ICS), we explore how pharmacy and medicines commissioning will work in the new system, with Laura Angus (Interim Lead Pharmacist, Humber, Coast and Vale ICS)In our December #WhispersWordsofWisdom webinar, Tom Clarke was joined by Laura Angus who, in her new appointment as a Lead Pharmacist in an Integrated Care System (ICS), is currently evaluating the impact of the transfers of budget and decision-making power from Clinical Commissioning Groups (CCGs) to an ICS. Her appointment as Interim Lead Pharmacist at Humber Coast and Vale ICS in November, follows 7-years as Head of Prescribing at NHS Vale of York CCG. Laura shares her frontline insights into the structural changes in the NHS, and what this means for pharmacy and the role of medicines.This episode was originally broadcast on 15th December 2020 as a webinar.Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/ 
Released:
Jan 13, 2021
Format:
Podcast episode

Titles in the series (56)

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access. Our first series focuses on the NHS response to the COVID-19 pandemic.